(0.51%) 5 214.08 points
(0.85%) 39 388 points
(0.27%) 16 346 points
(0.34%) $79.26
(5.62%) $2.31
(0.78%) $2 340.30
(2.77%) $28.37
(0.85%) $993.00
(-0.31%) $0.927
(-0.14%) $10.88
(-0.22%) $0.798
(0.87%) $92.53
5 days till quarter result
(bmo 2024-05-14)
Expected move: +/- 9.96%
@ $15.49
Utstedt: 14 feb 2024 @ 21:23
Avkastning: -6.07%
Forrige signal: feb 14 - 18:00
Forrige signal:
Avkastning: 1.51 %
Live Chart Being Loaded With Signals
Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role...
Stats | |
---|---|
Dagens volum | 580 754 |
Gjennomsnittsvolum | 840 057 |
Markedsverdi | 1.16B |
EPS | $0 ( 2024-05-07 ) |
Neste inntjeningsdato | ( $-0.510 ) 2024-05-14 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -7.31 |
ATR14 | $0.0190 (0.13%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-09 | Peng Katie | Buy | 35 767 | Stock Option (Right to Buy) |
2024-04-09 | Peng Katie | Buy | 26 825 | Common Stock |
2024-02-16 | Myles Edward H | Sell | 4 744 | Common Stock |
2024-02-16 | Qatanani Mo | Sell | 2 512 | Common Stock |
2024-02-16 | Parlavecchio Caryn | Sell | 3 751 | Common Stock |
INSIDER POWER |
---|
57.30 |
Last 96 transactions |
Buy: 9 442 259 | Sell: 2 434 527 |
Volum Korrelasjon
Scholar Rock Holding Corp Korrelasjon
10 Mest positive korrelasjoner | |
---|---|
FOX | 0.897 |
FOXA | 0.891 |
CRTO | 0.889 |
GOODM | 0.882 |
BPRN | 0.882 |
IMAB | 0.872 |
DSKE | 0.872 |
CIGI | 0.867 |
CVCY | 0.86 |
CINF | 0.86 |
10 Mest negative korrelasjoner | |
---|---|
NESR | -0.841 |
IMPP | -0.83 |
SFBC | -0.818 |
SGII | -0.812 |
FRG | -0.812 |
HBANO | -0.812 |
MRM | -0.809 |
ARCE | -0.807 |
PTMN | -0.802 |
EGLE | -0.801 |
Visste du det?
Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).
Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.
Scholar Rock Holding Corp Korrelasjon - Valuta/Råvare
Scholar Rock Holding Corp Økonomi
Annual | 2023 |
Omsetning: | $0 |
Bruttogevinst: | $-2.84M (0.00 %) |
EPS: | $-1.990 |
FY | 2023 |
Omsetning: | $0 |
Bruttogevinst: | $-2.84M (0.00 %) |
EPS: | $-1.990 |
FY | 2022 |
Omsetning: | $33.19M |
Bruttogevinst: | $23.31M (70.22 %) |
EPS: | $-2.21 |
FY | 2021 |
Omsetning: | $18.82M |
Bruttogevinst: | $0.00 (0.00 %) |
EPS: | $-3.59 |
Financial Reports:
No articles found.
Scholar Rock Holding Corp
Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clinical trials for the treatment of spinal muscular atrophy; and SRK-181, which is in Phase 1 clinical trials for the treatment of cancers that are resistant to checkpoint inhibitor therapies, such as anti-PD-1 or anti-PD-L1 antibody therapies. It is also developing a pipeline of novel product candidates with potential to transform the lives of patients suffering from a range of serious diseases, including neuromuscular disorders, cancer, and fibrosis. The company has a collaboration agreement with Gilead Sciences, Inc. to discover and develop specific inhibitors of transforming growth factor beta activation for the treatment of fibrotic diseases. Scholar Rock Holding Corporation was founded in 2012 and is headquartered in Cambridge, Massachusetts.
Om Live Signaler
Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.
Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.